New vectors for the construction of double recombinant adenoviruses

Journal of Virological Methods

Volumn 81, Issue 1-2, 1999, Pages 11-20

  Danthinne, Xavier ^a,b  

^a Boise VA Medical Center   (United States)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

Adenovirus; Gene therapy; Gene transfer; Viral vectors

Indexed keywords

BETA GALACTOSIDASE; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; COSMID; ESCHERICHIA COLI; GENE CASSETTE; GENE TRANSFER; MOLECULAR CLONING; PLASMID; PRIORITY JOURNAL; TECHNIQUE; VIRUS RECOMBINANT;

ADENOVIRIDAE; CELLS, CULTURED; CLONING, MOLECULAR; COSMIDS; DNA, VIRAL; GENETIC VECTORS; HUMANS; MUTAGENESIS, INSERTIONAL; RECOMBINATION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED;

ADENOVIRIDAE;

EID: 0032771701     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(99)00054-3     Document Type: Article

References (26)

1. Bett A.J., Haddara W., Prevec L., Graham F.L. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc. Natl. Acad. Sci. USA. 91:1994;8802-8806.
2. Bramson J., Hitt M., Gallichan W.S., Rosenthal K.L., Gauldie J., Graham F.L. Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine, in vitro and in vivo production of biologically active interleukin-12. Hum. Gene Ther. 7:1996;333-342.
3. Castleden S.A., Chong H., Garcia-Ribas I., Melcher A.A., Hutchinson G., Roberts B., Hart I.R., Vile R.G. A family of bicistronic vectors to enhance both local and systemic antitumor effects of HSVtk or cytokine expression in a murine melanoma model. Hum. Gene Ther. 8:1997;2087-2102.
4. Cepko, C., 1987. XGal staining of cultured cells. In: Ausubel, F.M. et al. (Eds.), Current Protocols in Molecular Biology. Wiley, New York, Suppl. 17, pp. 9.11.9-9.11.12.
5. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:1996;4805-4810.
6. Chen L., Chen D., Block E., O'Donnell M., Kufe D.W., Clinton S.K. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J. Immunol. 159:1997;351-359.
7. Crouzet J., Naudin L., Orsini C., Vigne E., Ferrero L., Le Roux A., Benoit P., Latta M., Torrent C., Branellec D., Denefle P., Mayaux J.-F., Perricaudet M., Yeh P. Recombinational construction in Escherichia coli of infectious adenoviral genomes. Proc. Natl. Acad. Sci. USA. 94:1997;1414-1419.
8. Emtage P.C., Wan Y., Bramson J.L., Graham F.L., Gauldie J. A double recombinant adenovirus expressing the costimulatory molecule B7-1 (murine) and human IL-2 induces complete tumor regression in a murine breast adenocarcinoma model. J. Immunol. 160:1998;2531-2538.
9. Fallaux F.J., Kranenburg O., Cramer S.J., Houweling A., Van Ormondt H., Hoeben R.C., Van Der Eb A. Characterisation of 911, a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7:1996;215-222.
10. Graham F.L., Smiley J., Russel W.C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:1977;59-74.
11. He X.S., Rivkina M., Robinson W.S. Construction of adenoviral and retroviral vectors coexpressing the genes encoding the hepatitis B surface antigen and B7-1 protein. Gene. 175:1996;121-125.
12. Hersh J., Crystal R.G., Bewig B. Modulation of gene expression after replication-deficient, recombinant adenovirus-mediated gene transfer by the product of a second adenovirus vector. Gene Ther. 2:1995;124-131.
13. Hirt B. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:1967;365-369.
14. Ketner G., Spencer F., Tugendreich S., Connelly C., Hieter P. Efficient manipulation of the human adenovirus genome as an infectious yeast artificial chromosome clone. Proc. Natl. Acad. Sci. USA. 91:1994;6186-6190.
15. Kochanek S., Clemens P.R., Mitani K., Chen H.-H., Chan S., Caskey C.T. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. USA. 93:1996;5731-5736.
16. Leach D.R.F., Stahl F.W. Viability of λ phages carrying a perfect palindrome in the absence of recombination nucleases. Nature. 305:1983;448-451.
17. Mittereder N., March K.L., Trapnell B.C. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy. J. Virol. 70:1996;7498-7509.
18. Miwa T., Matsubara K. Lambda phage DNA sequences affecting the packaging process. Gene. 24:1983;199-206.
19. Oka A., Sugisaki H., Takanami M. Nucleotide sequence of the kanamycin resistance transposon Tn903. J. Mol. Biol. 147:1981;217-226.
20. Prentki P. Nucleotide sequence of the classical lacZ deletion delta M15. Gene. 122:1992;231-232.
21. Pützer B.M., Hitt M., Muller W.J., Emtage P., Gauldie J., Graham F.L. Interleukin 12 and B7-1 costimulatory molecule expressed by an adenovirus vector act synergistically to facilitate tumor regression. Proc. Natl. Acad. Sci. USA. 94:1997;10889-10894.
22. Robbins P.D., Tahara H., Ghivizzani S.C. Viral vectors for gene therapy. Trends Biotechnol. 16:1998;35-40.
23. Tomanin R., Bett A.J., Picci L., Scarpa M., Graham F.L. Development and characterisation of a binary gene expression system based on bacteriophage T7 components in adenovirus vectors. Gene. 193:1997;129-140.
24. Twigg A.J., Sherratt D. Transcomplementable copy-number mutants of plasmid colE1. Nature. 283:1980;216-218.
25. Watson N. A new revision of the sequence of plasmid pBR322. Gene. 70:1988;399-403.
26. Yanish-Perron C., Vieira J., Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequence of the M13mp18 and pUC19 vectors. Gene. 33:1985;103-119.